Liangjie Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Liangjie Lin has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Ailian Liu
Department of Radiology, the First Affiliated Hospital of Dalian Medical University
6 shared publications - Jiazheng Wang
Clinical & Technical Support, Philips Healthcare, Beijing, China
3 shared publications Changjun Ma
School of Biomedical Engineering, Faculty of Medicine, Dalian University of Technology, Dalian, China; Stem Cell Clinical Research Center, National Joint Engineering Laboratory, Regenerative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China; Dalian Innovation Institute of Stem Cell and Precision Medicine, Dalian, Liaoning Province, China
2 shared publicationsLihua Chen
Department of Radiology, the First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, China
2 shared publications- Lihua Chen
The First Affiliated Hospital of Dalian Medical University
2 shared publications Nan Wang
The First Affiliated Hospital of Dalian Medical University
2 shared publications
Latest Publications
- 20 August 2026
- Published by Springer Nature in Abdominal Radiology
- p. 1-11
Intravoxel incoherent motion imaging with improved image quality by deep learning reconstruction for prediction of lymph-vascular space invasion in patients with cervical cancer
Purpose To evaluate the performance of intravoxel incoherent motion (IVIM) imaging with deep learning reconstruction (DLR) for prediction of lymph-vascular space invasion (LVSI) in cervical cancer (CC). Methods Patients clinically suspected of having CC who underwent uterine MRI were retrospectively collected. IVIM images were collected with b values of 0, 20, 50, 100, 150, 200, 400, 800, 1500 and 2000 s/mm2. Subjective image quality, signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), as well as apparent diffusion coefficient (ADC) values calculated at b = 0 and 800 s/mm² (ADC800), ADC values at b = 0 and 2000 s/mm² (ADC2000), and IVIM quantitative parameters were computed and compared between IVIM sequences with and without DLR. Quantitative parameters measured by the two sets of IVIM data were also compared between LVSI-positive and LVSI-negative groups. Results The study included 55 patients with 31/55 (56.36%) lesions identified as LVSI positive. IVIM images with DLR were associated with significantly higher image quality scores, SNR, and CNR than those without DLR. All quantitative parameters except ADC800 showed significant differences between the two data sets. For both IVIM with and without DLR, the ADC2000 and true diffusion coefficient (D) values were significantly different between LVSI-positive and LVSI-negative groups. The combination of ADC2000 and D measured from IVIM images with DLR yield the highest AUC of 0.809. Conclusion Reconstruction of pelvic IVIM images with DLR significantly improved image quality. IVIM parameters derived from DLR images showed potential for non-invasive prediction of LVSI status in CC.
- 20 August 2026
- Published by Springer Nature in Abdominal Radiology
- p. 1-11
Intravoxel incoherent motion imaging with improved image quality by deep learning reconstruction for prediction of lymph-vascular space invasion in patients with cervical cancer
Purpose To evaluate the performance of intravoxel incoherent motion (IVIM) imaging with deep learning reconstruction (DLR) for prediction of lymph-vascular space invasion (LVSI) in cervical cancer (CC). Methods Patients clinically suspected of having CC who underwent uterine MRI were retrospectively collected. IVIM images were collected with b values of 0, 20, 50, 100, 150, 200, 400, 800, 1500 and 2000 s/mm2. Subjective image quality, signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), as well as apparent diffusion coefficient (ADC) values calculated at b = 0 and 800 s/mm² (ADC800), ADC values at b = 0 and 2000 s/mm² (ADC2000), and IVIM quantitative parameters were computed and compared between IVIM sequences with and without DLR. Quantitative parameters measured by the two sets of IVIM data were also compared between LVSI-positive and LVSI-negative groups. Results The study included 55 patients with 31/55 (56.36%) lesions identified as LVSI positive. IVIM images with DLR were associated with significantly higher image quality scores, SNR, and CNR than those without DLR. All quantitative parameters except ADC800 showed significant differences between the two data sets. For both IVIM with and without DLR, the ADC2000 and true diffusion coefficient (D) values were significantly different between LVSI-positive and LVSI-negative groups. The combination of ADC2000 and D measured from IVIM images with DLR yield the highest AUC of 0.809. Conclusion Reconstruction of pelvic IVIM images with DLR significantly improved image quality. IVIM parameters derived from DLR images showed potential for non-invasive prediction of LVSI status in CC.
- Open Access
- 24 February 2026
- Published by Elsevier in Brain Research Bulletin
- Vol. 237, 111787
Dynamics of hidden brain states in post-stroke cognitive impairment: Linking neural activity to neurotransmitter systems and genetic pathways
- 24 February 2026
- Published by Elsevier in Brain Research Bulletin
- Vol. 237, 111787
Open AccessDynamics of hidden brain states in post-stroke cognitive impairment: Linking neural activity to neurotransmitter systems and genetic pathways
- Open Access
- 12 December 2025
- Published by Springer Nature in Research Square
Feasibility of deep learning-based super-resolution reconstruction for endometrial cancer T2-weighted imaging
Background No study has assessed the application of deep learning (DL) networks in combination with more advanced super-resolution (SR) reconstruction for endometrial cancer (EC) MRI and the influence of this methods on myometrial invasion. We aimed to evaluate the performance and clinical value of DL-based SR reconstruction for image quality improvement in under-sampling accelerated EC T2WI. Methods Two sets of T2WI were acquired for 23 volunteers with low (T2 LR ) and high (T2 HR ) resolution, respectively. For 41 EC patients, T2 LR and MultiVane T2WI (T2 MV ) were performed. T2 SR images were reconstructed from T2 LR through DL network. Image quality and diagnostic accuracy were evaluated by radiologists. Results For 23 volunteers, the signal-to-noise ratio and peak signal-to-noise ratio of T2 SR were notably higher than those of T2 LR and T2 HR , and the edge rise distance of T2 SR was lower ( P < 0.005). For 41 EC patients, the image sharpness, capsule delineation, overall image quality, and diagnostic confidence of T2 SR and T2 MV were notably higher than those of T2 LR ( P < 0.005). Compared with T2 MV , the scanning time of T2 SR was reduced by 61% (50s vs. 128s). T2 SR and T2 MV images had similar diagnostic accuracy for myometrial invasion assessed by radiologists. Conclusions DL-based super-resolution reconstruction significantly improved the image quality of uterus T2WI compared to the conventional iterative reconstruction by compressed sensing, saving scanning time and ensuring the accurate evaluation of myometrial invasion of endometrial cancer.
- 12 December 2025
- Published by Springer Nature in Research Square
Open AccessFeasibility of deep learning-based super-resolution reconstruction for endometrial cancer T2-weighted imaging
Background No study has assessed the application of deep learning (DL) networks in combination with more advanced super-resolution (SR) reconstruction for endometrial cancer (EC) MRI and the influence of this methods on myometrial invasion. We aimed to evaluate the performance and clinical value of DL-based SR reconstruction for image quality improvement in under-sampling accelerated EC T2WI. Methods Two sets of T2WI were acquired for 23 volunteers with low (T2 LR ) and high (T2 HR ) resolution, respectively. For 41 EC patients, T2 LR and MultiVane T2WI (T2 MV ) were performed. T2 SR images were reconstructed from T2 LR through DL network. Image quality and diagnostic accuracy were evaluated by radiologists. Results For 23 volunteers, the signal-to-noise ratio and peak signal-to-noise ratio of T2 SR were notably higher than those of T2 LR and T2 HR , and the edge rise distance of T2 SR was lower ( P < 0.005). For 41 EC patients, the image sharpness, capsule delineation, overall image quality, and diagnostic confidence of T2 SR and T2 MV were notably higher than those of T2 LR ( P < 0.005). Compared with T2 MV , the scanning time of T2 SR was reduced by 61% (50s vs. 128s). T2 SR and T2 MV images had similar diagnostic accuracy for myometrial invasion assessed by radiologists. Conclusions DL-based super-resolution reconstruction significantly improved the image quality of uterus T2WI compared to the conventional iterative reconstruction by compressed sensing, saving scanning time and ensuring the accurate evaluation of myometrial invasion of endometrial cancer.
- 15 October 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70  (20) , 205015
Fast water/fat T 2 and PDFF mapping via multiple overlapping-echo detachment acquisition and deep learning reconstruction
Objective. Rapid and accurate quantitative assessment of muscle tissue characteristics is valuable for the diagnosis and monitoring of neuromuscular diseases (NMDs). Quantitative magnetic resonance imaging (MRI) enables non-invasive assessment of muscle pathology by using water T 2 values to assess muscle damage and proton density fat fraction (PDFF) to quantify fat infiltration. However, conventional methods for simultaneous water-fat separation and T 2 quantification often require long acquisition times. This study aims to develop an ultrafast method for simultaneous water-fat separation and T 2 quantification. Approach. A novel water-fat separation framework that combines chemical shift encoding with the multiple overlapping-echo detachment sequence (CSE-MOLED) was proposed. Synthetic training data and deep learning-based reconstruction were employed to address challenges in water-fat separation, including the complex multi-peak spectral characteristic of fat and the non-idealities in MRI acquisition. All experiments, including phantom and in vivo scans, were performed on a 3T MRI scanner. The in vivo experiments focused on the human thigh and involved five healthy volunteers, one subject with muscle atrophy, and one with muscle damage. The CSE-MOLED sequence was acquired with a spatial resolution of 1.72 mm × 1.72 mm × 5 mm. For reference, mDixon-TSE (Turbo Spin Echo) was performed to generate PDFF, water T 2, and fat T 2 maps. Main results. In numerical experiments (T 2 range: water 19–160 ms, fat 15–160 ms; PDFF range: 14%–100%), the R 2 values were all 0.999 for water T 2, fat T 2, and PDFF, with average percentage errors of 3.16%, 0.98%, and 0.78%, respectively. In phantom experiments (T 2 range: water 35–125 ms, fat 36–47 ms; PDFF range: 14–36%), the R 2 values were 0.995, 0.733, and 0.996 for water T 2, fat T 2, and PDFF, with average percentage errors of 5.56%, 2.93%, and 1.77%, respectively. High repeatability (coefficient of variation in vivo experiments. In patient scans, CSE-MOLED successfully distinguished between fat infiltration and muscle damage. Significance. CSE-MOLED simultaneously obtains T 2 and proton density maps for both water and fat, along with T 2-corrected PDFF map, in 162 ms per slice of acquisition time, offering the potential to enhance the diagnostic accuracy of NMDs without increasing the clinical scanning burden.
- 15 October 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70  (20) , 205015
Fast water/fat T 2 and PDFF mapping via multiple overlapping-echo detachment acquisition and deep learning reconstruction
Objective. Rapid and accurate quantitative assessment of muscle tissue characteristics is valuable for the diagnosis and monitoring of neuromuscular diseases (NMDs). Quantitative magnetic resonance imaging (MRI) enables non-invasive assessment of muscle pathology by using water T 2 values to assess muscle damage and proton density fat fraction (PDFF) to quantify fat infiltration. However, conventional methods for simultaneous water-fat separation and T 2 quantification often require long acquisition times. This study aims to develop an ultrafast method for simultaneous water-fat separation and T 2 quantification. Approach. A novel water-fat separation framework that combines chemical shift encoding with the multiple overlapping-echo detachment sequence (CSE-MOLED) was proposed. Synthetic training data and deep learning-based reconstruction were employed to address challenges in water-fat separation, including the complex multi-peak spectral characteristic of fat and the non-idealities in MRI acquisition. All experiments, including phantom and in vivo scans, were performed on a 3T MRI scanner. The in vivo experiments focused on the human thigh and involved five healthy volunteers, one subject with muscle atrophy, and one with muscle damage. The CSE-MOLED sequence was acquired with a spatial resolution of 1.72 mm × 1.72 mm × 5 mm. For reference, mDixon-TSE (Turbo Spin Echo) was performed to generate PDFF, water T 2, and fat T 2 maps. Main results. In numerical experiments (T 2 range: water 19–160 ms, fat 15–160 ms; PDFF range: 14%–100%), the R 2 values were all 0.999 for water T 2, fat T 2, and PDFF, with average percentage errors of 3.16%, 0.98%, and 0.78%, respectively. In phantom experiments (T 2 range: water 35–125 ms, fat 36–47 ms; PDFF range: 14–36%), the R 2 values were 0.995, 0.733, and 0.996 for water T 2, fat T 2, and PDFF, with average percentage errors of 5.56%, 2.93%, and 1.77%, respectively. High repeatability (coefficient of variation in vivo experiments. In patient scans, CSE-MOLED successfully distinguished between fat infiltration and muscle damage. Significance. CSE-MOLED simultaneously obtains T 2 and proton density maps for both water and fat, along with T 2-corrected PDFF map, in 162 ms per slice of acquisition time, offering the potential to enhance the diagnostic accuracy of NMDs without increasing the clinical scanning burden.
- Open Access
- 6 January 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 11, 1536630
Editorial: Methods and applications of tumour metabolic imaging in the preclinical and clinical setting
It is becoming increasingly evident that altered metabolism contributes to tumor progression and has been recognized as a hallmark of cancer. The cancer metabolic heterogeneity may result from genetic diversity, complex metabolic pathways, and altered microenvironmental conditions in tumors. Imaging tumor metabolism has been remarkably successful in recent years. Numerous studies demonstrated that malignant tumors could be detected with high sensitivity and specificity by imaging their increased metabolic rates for glucose, amino acids, or lipids [1][2][3]. However, there remain emerging needs for extended studies on the metabolic dependencies of human cancer in vivo to understand how metabolism shapes and defines cancer initiation, progression and response to treatment. Several non-invasive imaging techniques can provide both functional and anatomical information related to tumor metabolism, including positron emission tomography (PET), magnetic resonance imaging (MRI), computed tomography (CT), and optical imaging utilizing bioluminescence etc. These methods may hold the key to helping improve cancer diagnoses and treatments. In this Research Topic "Methods and Applications of Tumor Metabolic Imaging in the Preclinical and Clinical Setting", researchers have demonstrated the potential of different metabolic imaging methods with preclinical and clinical setups for the diagnosis and treatment in a range of tumors.Neoadjuvant chemotherapy (NAC) has become the standard treatment option for locally advanced breast cancer. Early and accurate prediction of tumor response to NAC is critical for treatment management. Currently, there is still no standard method or imaging biomarker in clinical practice to accurately predict the pathological complete response (pCR) to NAC in breast cancer patients. Amide proton transfer weighted (APTw) imaging, which detects the exchange between water protons and amide protons in endogenous mobile proteins or polypeptides in tissues, enables indirect detection of changes in protein synthesis and related pathophysiological features in living cells. Zhang et al. [4] hypothesized that APTw imaging may be a potential tool for assessing the response of breast cancer (especially, the early response) to NAC. And results demonstrated that high sensitivity performance can be achieved by APTw for early prediction of MHR status at the end of the first two NAC cycles, which might allow timely regimen refinement before definitive surgical treatment. APTw in combination with tumor diameter and diffusion weighted imaging can further improve diagnostic accuracy.Benefits from specifically targeting and boosting resistant hypoxic tumor subvolumes have been promising in clinical attempts but inconclusive. And it is necessary to carry out a comprehensive investigation on the efficacy of boosting hypoxic subvolumes defined by electron paramagnetic resonance oxygen imaging (EPROI). The study by Gertsenshteyn et al. [5] presents data in three preclinical mammalian tumor types to demonstrate that accurate targeting of hypoxic tumor subvolumes with a boost of radiation improves the local tumor control probability relative to a boost of the same integral dose to oxygenated regions of the tumor. This provides additional biologic validation of EPROI in targeting enough resistant hypoxic tumor subvolumes to increase the probability of eliminating all clonogens. It may provide a means of reducing the dose to oxygenated regions and delivering a radiation boost to resistant hypoxic regions. The boosting hypoxic subvolumes defined by EPROI can also help reduce dose to potential organs at risk when improves tumor control, promising the enhancement of the therapeutic ratio.Accurate staging of prostate cancer (PCa) is critical to disease management and treatment planning. Prostate-Specific Membrane Antigen (PSMA) is a transmembrane glycoprotein, overexpressed in prostate cancer cells. PSMA PET/CT, with excellent sensitivity and specificity, has now become the preferred staging modality for prostate cancer. Compared to other PSMAtargeted tracers, 18 F-PSMA-1007 is mainly cleared by the liver and bile (reduced urinary radioactive interference) thus allowing better assessment of lesions in the prostate and pelvic regions. However, obvious concentrations of 18 F-PSMA-1007 can still be observed in the bladder of some patients, which affects detection of lesions in the prostate and adjacent areas, especially in patients with clinical suspicion of biochemical recurrence, as long-term androgen deprivation therapy will significantly reduce the visibility of prostate lesions on PSMA PET/CT. Dang et al. [6] proposed to explore the cause of the high uptake of 18 F-PSMA-1007 in bladder urine by assessing the clinical characteristics and imaging characteristics of PCa patients. And results showed no significant correlation of the high uptake of 18 F-PSMA-1007 in bladder urine with age, height, weight, Gleason score, metastases, treatment methods, liver and kidney function levels, TPSA levels, 18 F-PSMA-1007 injected activity, the interval from injection to scan, the physiological distribution of parotid gland, kidney, liver, spleen, intestine, obturator internus, and the pathological distribution of prostate lesions. Therefore, more research is still needed to find out the causes of this problem, so as to improve the disease assessment in PCa patients.The PET detection of the radioactive glucose analog 2-18 F-fluoro-2-deoxy-d-glucose ( 18 FDG) is now widely used for tumor metabolic imaging. However, 18 FDG-PET often provides ambiguous results in organs with intrinsic high glucose uptake (such as the brain) and does not inform on metabolism downstream of glucose uptake. Deuterium metabolic imaging (DMI), with combination of deuterium magnetic resonance spectroscopic imaging with oral intake or intravenous infusion of nonradioactive 2 H-labeled substrates, can noninvasively reveal the glucose metabolism flux...
- 6 January 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 11, 1536630
Open AccessEditorial: Methods and applications of tumour metabolic imaging in the preclinical and clinical setting
It is becoming increasingly evident that altered metabolism contributes to tumor progression and has been recognized as a hallmark of cancer. The cancer metabolic heterogeneity may result from genetic diversity, complex metabolic pathways, and altered microenvironmental conditions in tumors. Imaging tumor metabolism has been remarkably successful in recent years. Numerous studies demonstrated that malignant tumors could be detected with high sensitivity and specificity by imaging their increased metabolic rates for glucose, amino acids, or lipids [1][2][3]. However, there remain emerging needs for extended studies on the metabolic dependencies of human cancer in vivo to understand how metabolism shapes and defines cancer initiation, progression and response to treatment. Several non-invasive imaging techniques can provide both functional and anatomical information related to tumor metabolism, including positron emission tomography (PET), magnetic resonance imaging (MRI), computed tomography (CT), and optical imaging utilizing bioluminescence etc. These methods may hold the key to helping improve cancer diagnoses and treatments. In this Research Topic "Methods and Applications of Tumor Metabolic Imaging in the Preclinical and Clinical Setting", researchers have demonstrated the potential of different metabolic imaging methods with preclinical and clinical setups for the diagnosis and treatment in a range of tumors.Neoadjuvant chemotherapy (NAC) has become the standard treatment option for locally advanced breast cancer. Early and accurate prediction of tumor response to NAC is critical for treatment management. Currently, there is still no standard method or imaging biomarker in clinical practice to accurately predict the pathological complete response (pCR) to NAC in breast cancer patients. Amide proton transfer weighted (APTw) imaging, which detects the exchange between water protons and amide protons in endogenous mobile proteins or polypeptides in tissues, enables indirect detection of changes in protein synthesis and related pathophysiological features in living cells. Zhang et al. [4] hypothesized that APTw imaging may be a potential tool for assessing the response of breast cancer (especially, the early response) to NAC. And results demonstrated that high sensitivity performance can be achieved by APTw for early prediction of MHR status at the end of the first two NAC cycles, which might allow timely regimen refinement before definitive surgical treatment. APTw in combination with tumor diameter and diffusion weighted imaging can further improve diagnostic accuracy.Benefits from specifically targeting and boosting resistant hypoxic tumor subvolumes have been promising in clinical attempts but inconclusive. And it is necessary to carry out a comprehensive investigation on the efficacy of boosting hypoxic subvolumes defined by electron paramagnetic resonance oxygen imaging (EPROI). The study by Gertsenshteyn et al. [5] presents data in three preclinical mammalian tumor types to demonstrate that accurate targeting of hypoxic tumor subvolumes with a boost of radiation improves the local tumor control probability relative to a boost of the same integral dose to oxygenated regions of the tumor. This provides additional biologic validation of EPROI in targeting enough resistant hypoxic tumor subvolumes to increase the probability of eliminating all clonogens. It may provide a means of reducing the dose to oxygenated regions and delivering a radiation boost to resistant hypoxic regions. The boosting hypoxic subvolumes defined by EPROI can also help reduce dose to potential organs at risk when improves tumor control, promising the enhancement of the therapeutic ratio.Accurate staging of prostate cancer (PCa) is critical to disease management and treatment planning. Prostate-Specific Membrane Antigen (PSMA) is a transmembrane glycoprotein, overexpressed in prostate cancer cells. PSMA PET/CT, with excellent sensitivity and specificity, has now become the preferred staging modality for prostate cancer. Compared to other PSMAtargeted tracers, 18 F-PSMA-1007 is mainly cleared by the liver and bile (reduced urinary radioactive interference) thus allowing better assessment of lesions in the prostate and pelvic regions. However, obvious concentrations of 18 F-PSMA-1007 can still be observed in the bladder of some patients, which affects detection of lesions in the prostate and adjacent areas, especially in patients with clinical suspicion of biochemical recurrence, as long-term androgen deprivation therapy will significantly reduce the visibility of prostate lesions on PSMA PET/CT. Dang et al. [6] proposed to explore the cause of the high uptake of 18 F-PSMA-1007 in bladder urine by assessing the clinical characteristics and imaging characteristics of PCa patients. And results showed no significant correlation of the high uptake of 18 F-PSMA-1007 in bladder urine with age, height, weight, Gleason score, metastases, treatment methods, liver and kidney function levels, TPSA levels, 18 F-PSMA-1007 injected activity, the interval from injection to scan, the physiological distribution of parotid gland, kidney, liver, spleen, intestine, obturator internus, and the pathological distribution of prostate lesions. Therefore, more research is still needed to find out the causes of this problem, so as to improve the disease assessment in PCa patients.The PET detection of the radioactive glucose analog 2-18 F-fluoro-2-deoxy-d-glucose ( 18 FDG) is now widely used for tumor metabolic imaging. However, 18 FDG-PET often provides ambiguous results in organs with intrinsic high glucose uptake (such as the brain) and does not inform on metabolism downstream of glucose uptake. Deuterium metabolic imaging (DMI), with combination of deuterium magnetic resonance spectroscopic imaging with oral intake or intravenous infusion of nonradioactive 2 H-labeled substrates, can noninvasively reveal the glucose metabolism flux...
- Open Access
- 30 August 2024
- Published by Elsevier in NeuroImage: Clinical
- Vol. 43, 103661
Unveiling MRI markers for Parkinson’s Disease: GABAergic dysfunction and cortical changes
- 30 August 2024
- Published by Elsevier in NeuroImage: Clinical
- Vol. 43, 103661
Open AccessUnveiling MRI markers for Parkinson’s Disease: GABAergic dysfunction and cortical changes
- Open Access
- 6 December 2023
- Published by MDPI AG in Bioengineering
- Vol. 10  (12) , 1399
Multimodal MRI for Estimating Her-2 Gene Expression in Endometrial Cancer
Purpose: To assess the value of multimodal MRI, including amide proton transfer-weighted imaging (APT), diffusion kurtosis imaging (DKI), and T2 mapping sequences for estimating human epidermal growth factor receptor-2 (Her-2) expression in patients with endometrial cancer (EC). Methods: A total of 54 patients with EC who underwent multimodal pelvic MRI followed by biopsy were retrospectively selected and divided into the Her-2 positive (n = 24) and Her-2 negative (n = 30) groups. Her-2 expression was confirmed by immunohistochemistry (IHC). Two observers measured APT, mean kurtosis (MK), mean diffusivity (MD), and T2 values for EC lesions. Results: The Her-2 (+) group showed higher APT values and lower MD and T2 values than the Her-2 (−) group (all p < 0.05); there was no significant difference in MK values (p > 0.05). The area under the receiver operating characteristic curve (AUC) of APT, MD, T2, APT + T2, APT + MD, T2 + MD, and APT + MD + T2 models to identify the two groups of cases were 0.824, 0.695, 0.721, 0.824, 0.858, 0.782, and 0.860, respectively, and the diagnostic efficacy after combined APT + MD + T2 value was significantly higher than those of MD and T2 values individually (p = 0.018, 0.028); the diagnostic efficacy of the combination of APT + T2 values was significantly higher than that of T2 values separately (p = 0.028). Weak negative correlations were observed between APT and T2 values (r = −0.365, p = 0.007), moderate negative correlations between APT and MD values (r = −0.560, p < 0.001), and weak positive correlations between MD and T2 values (r = 0.336, p = 0.013). The APT values were independent predictors for assessing Her-2 expression in EC patients. Conclusion: The APT, DKI, and T2 mapping sequences can be used to preoperatively assess the Her-2 expression in EC, which can contribute to more precise treatment for clinical preoperative.
- 6 December 2023
- Published by MDPI AG in Bioengineering
- Vol. 10  (12) , 1399
Open AccessMultimodal MRI for Estimating Her-2 Gene Expression in Endometrial Cancer
Purpose: To assess the value of multimodal MRI, including amide proton transfer-weighted imaging (APT), diffusion kurtosis imaging (DKI), and T2 mapping sequences for estimating human epidermal growth factor receptor-2 (Her-2) expression in patients with endometrial cancer (EC). Methods: A total of 54 patients with EC who underwent multimodal pelvic MRI followed by biopsy were retrospectively selected and divided into the Her-2 positive (n = 24) and Her-2 negative (n = 30) groups. Her-2 expression was confirmed by immunohistochemistry (IHC). Two observers measured APT, mean kurtosis (MK), mean diffusivity (MD), and T2 values for EC lesions. Results: The Her-2 (+) group showed higher APT values and lower MD and T2 values than the Her-2 (−) group (all p < 0.05); there was no significant difference in MK values (p > 0.05). The area under the receiver operating characteristic curve (AUC) of APT, MD, T2, APT + T2, APT + MD, T2 + MD, and APT + MD + T2 models to identify the two groups of cases were 0.824, 0.695, 0.721, 0.824, 0.858, 0.782, and 0.860, respectively, and the diagnostic efficacy after combined APT + MD + T2 value was significantly higher than those of MD and T2 values individually (p = 0.018, 0.028); the diagnostic efficacy of the combination of APT + T2 values was significantly higher than that of T2 values separately (p = 0.028). Weak negative correlations were observed between APT and T2 values (r = −0.365, p = 0.007), moderate negative correlations between APT and MD values (r = −0.560, p < 0.001), and weak positive correlations between MD and T2 values (r = 0.336, p = 0.013). The APT values were independent predictors for assessing Her-2 expression in EC patients. Conclusion: The APT, DKI, and T2 mapping sequences can be used to preoperatively assess the Her-2 expression in EC, which can contribute to more precise treatment for clinical preoperative.
- 11 April 2023
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 102, 43-48
Improved differentiation between stage I-II endometrial carcinoma and endometrial polyp with combination of APTw and IVIM MR imaging
- 11 April 2023
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 102, 43-48
Improved differentiation between stage I-II endometrial carcinoma and endometrial polyp with combination of APTw and IVIM MR imaging
- 1 April 2022
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 87, 177-182
Amide proton transfer magnetic resonance imaging to evaluate renal impairment in patients with chronic kidney disease
- 1 April 2022
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 87, 177-182
Amide proton transfer magnetic resonance imaging to evaluate renal impairment in patients with chronic kidney disease